Brief: Olema Oncology Q2 Net Income USD -30.382 Million
06/08/2024 21:02
Aug 06 (Reuters) - Olema Oncology Q2 operating expenses USD 33.53 million. * Q2 basic EPS USD -0.54 vs. IBES estimate USD -0.55 * Q2 income from operations USD -33.53 million
Recent news on Olema Oncology
See all newsBrief: Olema Pharmaceuticals Changes Corporate Name To Olema Oncology, Effective Today
Olema Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
Olema Pharma Q3 net loss widens on higher costs
Brief: Olema Pharmaceuticals Q3 Net Income USD -73.599 Million
Olema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary